Breast cancer: influence of endocrine hormones, growth factors and genetic alterations.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Advances in Experimental Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-1-4615-2926-2_10PMID 8368129
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Breast Cancer: Cellular and Molecular Biology

  2011cited by this paper
• Epidermal growth factor receptors in human breast cancer

  2005cited by this paper
• Immunological detection and quantitation of alpha transforming growth factors in human breast carcinoma cells

  2005cited by this paper
• Role of the retinoblastoma gene in the oncogenesis of human breast carcinoma.

  1991cited by this paper
• The insulin-like growth factors, their receptors, and their binding proteins in human breast cancer.

  1991cited by this paper
• Regulatory Mechanisms in Breast Cancer

  1991cited by this paper
• Oncogenes as clinical prognostic indicators.

  1991cited by this paper
• Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions.

  1991cited by this paper
• Steroids, growth factors, and cell cycle controls in breast cancer.

  1991cited by this paper
• Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.

  1990cited by this paper
• Progestin regulation of cellular proliferation.

  1990cited by this paper
• Suppressors of the malignant phenotype.

  1990cited by this paper
• Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation

  1990cited by this paper
• TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas.

  1990cited by this paper
• Transforming growth factor-alpha messenger RNA localization in the developing adult rat and human mammary gland by in situ hybridization.

  1990cited by this paper
• The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity

  1990cited by this paper
• Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast

  1990cited by this paper
• Estrogen stimulates transcription of c-jun protooncogene.

  1990cited by this paper
• Transforming Growth Factor‐β

  1990cited by this paper
• Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.

  1990cited by this paper
• Development of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice

  1990cited by this paper
• Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice.

  1990cited by this paper
• Characterization of mammary-derived growth factor 1 receptors and response in human mammary epithelial cell lines.

  1990cited by this paper
• Developmental regulation of mammary-derived growth inhibitor expression in bovine mammary tissue

  1990cited by this paper
• Epithelium-dependent extracellular matrix synthesis in transforming growth factor-beta 1-growth-inhibited mouse mammary gland

  1990cited by this paper
• Transforming Growth Factor-β Induces Platelet-Derived Growth Factor (PDGF) Messenger RNA and PDGF Secretion while Inhibiting Growth in Normal Human Mammary Epithelial Cells

  1990cited by this paper
• The retinoblastoma gene and cell growth control.

  1990cited by this paper
• Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol.

  1990cited by this paper
• Expression of the transforming growth factor-alpha/epidermal growth factor receptor pathway in normal human breast epithelial cells.

  1990cited by this paper
• Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer.

  1990cited by this paper
• A Mr 43,000 epidermal growth factor-related protein purified from the urine of breast cancer patients.

  1990cited by this paper
• Inhibition of mouse mammary ductal morphogenesis and down-regulation of the EGF receptor by epidermal growth factor.

  1990cited by this paper
• Inherited predisposition to cancer.

  1990cited by this paper
• Transforming growth factor-beta induces platelet-derived growth factor (PDGF) messenger RNA and PDGF secretion while inhibiting growth in normal human mammary epithelial cells.

  1990cited by this paper
• Stromal influences on transformation of human mammary epithelial cells overexpressing c‐myc and SV40T

  1990cited by this paper
• Stimulation of epithelial membrane antigen expression by transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells.

  1989cited by this paper
• Transforming Growth Factor α Production and Epidermal Growth Factor Receptor Expression in Normal and Oncogene Transformed Human Mammary Epithelial Cells

  1989cited by this paper
• Monoclonal antibody targeting of liposomes to mouse lung in vivo.

  1989cited by this paper
• Immortalization and malignant transformation of differentiated cells by oncogenes in vitro and in transgenic mice.

  1989cited by this paper
• Production of mammastatin, a tissue-specific growth inhibitor, by normal human mammary cells.

  1989cited by this paper
• Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cells.

  1989cited by this paper
• Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

  1989cited by this paper
• Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells.

  1989cited by this paper
• Transforming growth factor alpha production and epidermal growth factor receptor expression in normal and oncogene transformed human mammary epithelial cells.

  1989cited by this paper
• Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene.

  1989cited by this paper
• Structure and function of human amphiregulin: a member of the epidermal growth factor family.

  1989cited by this paper
• Proliferative stimuli in the normal breast: estrogens or progestins?

  1989cited by this paper
• Role of a tumor-suppressor gene in the negative control of anchorage-independent growth of Syrian hamster cells.

  1989cited by this paper
• Growth regulation of breast cancer.

  1989cited by this paper
• Insulin‐like growth factor‐1 receptors and insulin‐like growth factor‐1‐like activity in human primary breast cancer

  1989cited by this paper
• Transformation of an established mouse mammary epithelial cell line following transfection with a human transforming growth factor alpha cDNA

  1989cited by this paper
• Regulation of transforming growth factor alpha and transforming growth factor beta messenger ribonucleic acid abundance in T-47D, human breast cancer cells.

  1989cited by this paper
• Transformation of mouse mammary epithelial cells with the Ha‐ras but not with the neu oncogene results in a gene dosage‐dependent increase in transforming growth factor‐α production

  1989cited by this paper
• The effects of a constitutive expression of transforming growth factor-alpha on the growth of MCF-7 human breast cancer cells in vitro and in vivo.

  1989cited by this paper
• Approaches to studying the role of growth factors in the progression of breast tumours from the steroid sensitive to insensitive state.

  1989cited by this paper
• Regulation of Transforming Growth Factor α and Transforming Growth Factor β Messenger Ribonucleic Acid Abundance in T-47D, Human Breast Cancer Cells

  1989cited by this paper
• Transforming growth factors type β1 and β2 are equipotent growth inhibitors of human breast cancer cell lines

  1989cited by this paper
• Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.

  1989cited by this paper
• Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines.

  1989cited by this paper
• Epidermal and transforming growth factor alpha in patients with breast tumours.

  1989cited by this paper
• Mutations in the p53 gene occur in diverse human tumour types

  1989cited by this paper
• Induction of transforming growth factor alpha expression in mouse mammary epithelial cells after transformation with a point-mutated c-Ha-ras protooncogene.

  1988cited by this paper
• The preneoplastic state in mouse mammary tumorigenesis.

  1988cited by this paper
• Control of human breast cancer by estrogen, growth factors, and oncogenes.

  1988cited by this paper
• Growth factor expression in normal, benign, and malignant breast tissue

  1988cited by this paper
• Heterodimeric transforming growth factor beta. Biological properties and interaction with three types of cell surface receptors.

  1988cited by this paper
• Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis.

  1988cited by this paper
• Induction of Transforming Growth Factor α Expression in Mouse Mammary Epithelial Cells after Transformation with a Point-Mutated c-Ha-ras Protooncogene

  1988cited by this paper
• Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.

  1988cited by this paper
• Insulin-like growth factor II mRNA expression in human breast cancer.

  1988cited by this paper
• Epidermal growth factor gene expression in human breast cancer cells: regulation of expression by progestins.

  1988cited by this paper
• In vivo amplification and rearrangement of c-myc oncogene in human breast tumors.

  1988cited by this paper
• Immunoreactive alpha transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosis.

  1988cited by this paper
• Regulation of development of the normal mammary gland by hormones and growth factors.

  1988cited by this paper
• Proliferative and secretory activity in human breast during natural and artificial menstrual cycles.

  1988cited by this paper
• Targeted c‐myc gene expression in mammary glands of transgenic mice induces mammary tumours with constitutive milk protein gene transcription.

  1988cited by this paper
• Tumor-associated growth factors in malignant rodent and human mammary epithelial cells.

  1988cited by this paper
• The role of epidermal growth factor in normal and neoplastic growth of mouse mammary epithelial cells.

  1988cited by this paper
• Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance.

  1988cited by this paper
• Ligand activation of overexpressed epidermal growth factor receptors transforms NIH 3T3 mouse fibroblasts.

  1988cited by this paper
• Transforming growth factor β: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells

  1988cited by this paper
• Transforming growth factor alpha.

  1988cited by this paper
• Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha‐transforming growth factors in ras‐transformed mouse mammary epithelial cells

  1987cited by this paper
• Transforming growth factor activity in pleural and peritoneal effusions from cancer and non-cancer patients.

  1987cited by this paper
• Production and auto-induction of transforming growth factor-α in human keratinocytes

  1987cited by this paper
• Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer.

  1987cited by this paper
• Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines.

  1987cited by this paper
• Identification of transforming growth factor alpha in human primary breast carcinomas.

  1987cited by this paper
• Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography.

  1987cited by this paper
• Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells.

  1987cited by this paper
• erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells.

  1987cited by this paper
• Mouse mammary tumors induced by medroxyprogesterone acetate: immunohistochemistry and hormonal receptors.

  1987cited by this paper
• Ha-ras oncogene expression directed by a milk protein gene promoter: tissue specificity, hormonal regulation, and tumor induction in transgenic mice.

  1987cited by this paper
• Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells.

  1987cited by this paper
• Modulation of transforming growth factor type beta action by activated ras and c-myc

  1987cited by this paper
• Urinary TGFs1 in neoplasia: immunoreactive TGF-alpha in the urine of patients with disseminated breast carcinoma.

  1987cited by this paper
• Prognostic significance of the expression of a ras protein with a molecular weight of 21,000 by human breast cancer.

  1987cited by this paper
• The human transforming growth factor type alpha coding sequence is not a direct-acting oncogene when overexpressed in NIH 3T3 cells.

  1987cited by this paper
• Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene.

  1987cited by this paper
• Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo.

  1987cited by this paper

• Circadian gating of epithelial-to-mesenchymal transition in breast cancer cells via melatonin-regulation of GSK3β.

  2012cites this paper
• IGF2 Promotes Activation of Estrogen Receptors in Basal-like Breast Cancer Cells

  2011cites this paper
• Expressão de genes homeobox em células de carcinoma epidermóide de boca estimuladas com EGF e TGF-beta

  2008cites this paper
• Mechanisms of EGF receptor regulation in breast cancer cells

  2004cites this paper
• Overexpression of vascular endothelial growth factor by MCF-7 breast cancer cells promotes estrogen-independent tumor growth in vivo.

  2003cites this paper
• Proteomic Dissection of Dome Formation in a Mammary Cell Line

  2002cites this paper
• Caveolin-1 phosphorylation in human squamous and epidermoid carcinoma cells: dependence on ErbB1 expression and Src activation.

  2002cites this paper
• Epidermal Growth Factor-stimulated Tyrosine Phosphorylation of Caveolin-1

  2000cites this paper
• An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.

  2000cites this paper
• Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line

  1999cites this paper
• Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties.

  1999cites this paper
• Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers.

  1999cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  1998cites this paper
• Mifepristone. Auxiliary therapeutic use in cancer and related disorders.

  1998cites this paper
• Cytokines in breast cancer cell dyshesion

  1998cites this paper
• Estrogen modulation of human breast cancer cell growth

  1997cites this paper
• The role of hormones, growth factors and vitamins in carcinogenesis.

  1996cites this paper
• Regulation and Role of TGFβ Production in Breast Cancer a

  1996cites this paper
• Regulation and role of TGF beta production in breast cancer.

  1996cites this paper
• Phosphorylation of the human estrogen receptor by mitogen-activated protein kinase and casein kinase II: consequence on DNA binding.

  1995cites this paper
• High cell kinetics is associated with amplification of the int‐2, bcl‐1, myc and erbB‐2 proto‐oncogenes and loss of heterozygosity at the DF3 locus in primary breast cancers

  1995cites this paper
• Expression of endothelin-1 immunoreactivity in breast cancer.

  1995cites this paper
• Midkine and pleiotrophin expression in normal and malignant breast tissue

  1994cites this paper
• Steroid receptor variants and their potential role in cancer.

  1994cites this paper